Literature DB >> 7226052

Malignant Leydig cell tumor: objective tumor response to o,p'-DDD.

P C Azer, G D Braunstein.   

Abstract

Leydig cell carcinoma of the testicle is a rare tumor with 16 well-documented cases in the medical literature. Radiotherapy and chemotherapy have not been successful in treating patients with metastatic disease. The patient described in this report had widely metastatic Leydig cell carcinoma associated with hypertension, hypokalemic alkalosis, and an elevated serum concentration of desoxycorticosterone. He experienced an objective clinical remission and disappearance of pulmonary metastases while receiving o,p'-DDD as the sole chemotherapeutic agent. This response was similar to that found in patients with adrenal cortical carcinoma. The regression of this tumor with an adrenolytic agent, in conjunction with the similar morphologic and biochemical features of these two types of tumors, provides additional evidence of the close similarity between Leydig cell carcinoma and adrenal cortical carcinoma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7226052     DOI: 10.1002/1097-0142(19810315)47:6<1251::aid-cncr2820470604>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  Malignant Leydig cell tumour of the testis: a case report and review of the literature.

Authors:  E Unlüer; D Ozcan; S Altin
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

Review 2.  Management of non-germinal testicular tumors.

Authors:  Michael C Risk; Christopher R Porter
Journal:  World J Urol       Date:  2009-03-26       Impact factor: 4.226

3.  Leydig cell tumor with lung metastasis diagnosed by lung biopsy.

Authors:  Ning Lai; Xin Zeng; Meichan Li; Jiaze Shu
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  Spinal cord compression by a solitary metastasis from a low grade leydig cell tumour: a case report and review of the literature.

Authors:  Efthimios P Samoladas; Ashraf S Anbar; Jonathan D Lucas; Hlias Fotiadis; Byron E Chalidis
Journal:  World J Surg Oncol       Date:  2008-07-10       Impact factor: 2.754

5.  Mitotane treatment in patients with metastatic testicular Leydig cell tumor associated with severe androgen excess.

Authors:  Vasileios Chortis; Nicholas J Johal; Irina Bancos; Matthew Evans; Kassiani Skordilis; Peter Guest; Michael H Cullen; Emilio Porfiri; Wiebke Arlt
Journal:  Eur J Endocrinol       Date:  2018-01-12       Impact factor: 6.664

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.